Merck & Co., Inc. (MRK), The Coca-Cola Company (KO): The Dow’s 5 Most Loved Stocks
Move over, Superman: There's a more unstoppable force that can leap even the highest expectations, and its name is the Dow Jones Industrial Average.
Posts Tagged ‘Merck & Co. Inc. (MRK)’
Genomic Health, Inc. (GHDX), Merck & Co., Inc. (MRK): Rest in Peace, Medicare?
Does Medicare have one foot in the grave already? The Trustees of the Medicare program recently announced that the program will remain solvent through 2026.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS): All About ASCO – 2013 Highlights
Every week at The Motley Fool we reflect on the top stories in the biotech sector in a wrap-up column.
Dendreon Corporation (DNDN), Celldex Therapeutics, Inc. (CLDX): A Promising Platform for Cancer Immunotherapy
A 2011 Nobel Prize in Physiology and Medicine is certainly impressive. Using a novel cancer treatment on yourself is both impressive and courageous. Dr.
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Should You Buy AstraZeneca plc (ADR) (AZN)?
Is AstraZeneca plc (ADR) (NYSE:AZN) a healthy stock for your portfolio? Investors who are in the know are getting more bullish.
Pfizer Inc. (PFE): Big Things Are Happening at This Pharmaceutical Company
Pharmaceutical company Pfizer Inc. (NYSE:PFE) has been doing some interesting things lately.
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS), Regulus Therapeutics Inc (RGLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Bristol Myers Squibb Co. (BMY): This Pharma Is Trading Like a Biotech
This chart is just unbelievable.
Why the Dow Jones Industrial Average (.DJI) Is Tumbling Today
What started out as a ho-hum day is turning into a rout.
How Irrationality Has Sparked the Dow Jones Industrial Average (.DJI)’s Triple-Digit Plunge
Down go the markets on renewed fears over an end to quantitative easing.
AT&T Inc. (T), Intel Corporation (INTC): These Winners Are Defying the Dow’s Reversal
Throughout the past four years, the bull market has repeatedly withstood challenges to its endurance, often coming back from substantial morning losses to finish higher on the...
Merck & Co., Inc. (MRK), Intel Corporation (INTC): Dow Fights to Keep Tuesday Winning Streak Alive
Investors received a little good news and a little better-than-expected news today.
Merck & Co., Inc. (MRK), Intel Corporation (INTC): 2 Big Winners and 2 Big Losers in the Dow Yesterday
Despite a poor report from the Institute for Supply Management showing that the Purchasing Managers Index contracted in May to 49, from April's 50.7, the major indexes all closed...
Merck & Co., Inc. (MRK), Celgene Corporation (CELG): 3 FDA Stories You Missed Last Week
Editor's Note: The initial article refers to Abraxane's prostate cancer trials. That is incorrect, Abraxane has priority review for pancreatic cancer.
Merck & Co., Inc. (MRK), Bristol Myers Squibb Co. (BMY): Breakthrough Melanoma Data Drives Pharmas Higher
Yesterday, Merck & Co., Inc. (NYSE:MRK) reported overwhelmingly positive interim results for its experimental melanoma drug lambrolizumab.
Merck & Co., Inc. (MRK), Bristol Myers Squibb Co. (BMY): Dow Beats Initial June Swoon
Though it's had its share of ups and downs this morning, the Dow Jones Industrial Average has kept its feet firmly in positive territory.
Merck & Co., Inc. (MRK), GlaxoSmithKline plc (ADR) (GSK): Three FDA Stories You Missed Last Week
The Food and Drug Administration stays busy with approvals, recommendations, and reviews.
Hedge Funds Are Selling GlaxoSmithKline plc (ADR) (GSK)
If you'd ask most stock holders, hedge funds are assumed to be underperforming, outdated financial vehicles of yesteryear.
AbbVie Inc (ABBV): Hedge Funds and Insiders Are Bullish, What Should You Do?
According to most market participants, hedge funds are assumed to be underperforming, old financial vehicles of yesteryear.
Three Things About to Move Johnson & Johnson (JNJ) Stock
Johnson & Johnson (NYSE:JNJ) may be involved in everything from hip implants to pharmaceuticals, but it's the latter that brings in the majority of the profits and fuels any...
Pfizer Inc. (PFE), Zoetis Inc (ZTS): 4 Investment Opportunities in Animal Health
Pfizer Inc. (NYSE:PFE) recently announced plans to sell its remaining 80% stake in animal-health company Zoetis Inc (NYSE:ZTS) after about four months on the public market.
Does Novartis AG (ADR) (NVS) Pass Buffett’s Test?
We'd all like to invest like the legendary Warren Buffett, turning thousands into millions or more.
Should You Trade Pfizer Inc. (PFE) Stock for Shares in Zoetis Inc (ZTS)?
Owners of Pfizer Inc. (NYSE:PFE) stock have an animal of a decision to make.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
US Bancorp (USB), General Electric Company (GE): The Six Most Generous States in America
Tragedy has always inspired Americans to give their support to those in need.
Johnson & Johnson (JNJ) Takes a Breather
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN): Right Drug Class, Wrong Company
We've been speculating for almost a year that Amarin Corporation plc (ADR) (NASDAQ:AMRN) would be purchased by AstraZeneca plc (ADR) (NYSE:AZN).
Merck & Co., Inc. (MRK): New Sleeping Aid Could Be an Awakening for This Pharma Giant
A recent review published online in the journal, The Lancet, found nearly a quarter of all adults are unhappy with their sleep patterns.
Merck & Co., Inc. (MRK), UnitedHealth Group Inc. (UNH): The Story Behind the Dow (.DJI)’s 200-Point Morning Surge
Following the three-day holiday weekend, investors came back to work to find the stock market soaring, with the Dow Jones Industrials climbing more than 200 points by 10:45 a...
Dendreon Corporation (DNDN), Bristol Myers Squibb Co. (BMY): Why Immunotherapy Stocks Could Be Set for a Big Move
If the JPMorgan Healthcare Conference in January is the mecca of all health-care events during the year, then the American Society of Clinical Oncology's annual meeting in Chicago...
AcelRx Pharmaceuticals Inc (ACRX), Peregrine Pharmaceuticals (PPHM): This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
This Metric Says You Are Smart to Sell Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Co. (NYSE:BMY) was in 33 hedge funds' portfolio at the end of the first quarter of 2013.
Merck & Co., Inc. (MRK) Stock Is a Good Investment (According to Merck)
The company announced Tuesday after the close that it had set up an accelerated share repurchase agreement with Goldman Sachs Group, Inc.
The Boeing Company (BA), Merck & Co., Inc. (MRK), Verizon Communications Inc. (VZ): Stocks Fall on Fear That Cheap Money May End Soon
This morning, the Dow Jones Industrial Average moved as high as 155 points before starting its descent and ending the day down 80 points, or 0.52%.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Four Big Drug Companies With Big Juicy Yields
Drug companies have been revenue generating machines for long.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY), AbbVie Inc (ABBV): The 5 Highest-Paying Dividend Stocks in Big Pharma
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Medtronic, Inc. (MDT), Merck & Co., Inc. (MRK), AutoZone, Inc. (AZO): Today’s Three Best Stocks
There's hardly any certainty in the market, but even I have to admit it's become almost comical that the Nasdaq Composite has hit a new high (including intraday highs) in 17 straight...
Merck & Co., Inc. (MRK): What Happened?
Federal Reserve officials seem to be having a running internal debate about the efficacy and future of quantitative easing.
Pfizer Inc. (PFE) Stock Checkup for May
We dread some checkups. Some people even put them off. If you own Pfizer Inc. (NYSE:PFE) stock, though, there's no need for dread or delay.
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): The Top Three Diseases Caused by Stress
Let's face it; we all dislike stress, but it's something we all live with to some degree.
Cisco Systems, Inc. (CSCO), Merck & Co., Inc. (MRK), The Coca-Cola Company (KO): Will These Stocks Stop the Dow’s Record Run Today?
This morning's movements in the Dow Jones Industrials look eerily familiar to those who have been watching the day-to-day movements of the average in recent months.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) – Pick Your Poison: Overweight or High Cholesterol
Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise...
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): Statin Users May Have a Reason to Rejoice After This Data
Whether or not you've been keeping tabs, the American Society of Clinical Oncology's annual meeting is less than two weeks away.
Merck & Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK): The U.S.’s Deadliest Diseases
There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
Zoetis Inc (ZTS), Pfizer Inc. (PFE): What About The Competition?
Dividend stocks are everywhere, but many just downright stink. In some cases, the business model is in serious jeopardy, or the dividend itself isn't sustainable.
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK) News: Expectations Of What’s Next, Gettin’ Bond-y & More
Nearly 400 former workers at Pfizer Inc.
The Home Depot, Inc. (HD), Wal-Mart Stores, Inc. (WMT), Merck & Co., Inc. (MRK): Markets Are Flat After Release of Poor Economic Data
Although homebuilder confidence is rising in May, the number of housing starts in April fell to a five-month low.
